Get the Stockscreener App
1.07
8.63%
0.085
After Hours:
1.06
-0.01
-0.93%
Icecure Medical Ltd stock is traded at $1.07, with a volume of 38.98M.
It is up +8.63% in the last 24 hours and up +4.90% over the past month.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
See More
Previous Close:
$0.985
Open:
$1.14
24h Volume:
38.98M
Relative Volume:
44.69
Market Cap:
$62.81M
Revenue:
$3.67M
Net Income/Loss:
$-13.83M
P/E Ratio:
-3.8214
EPS:
-0.28
Net Cash Flow:
$-10.79M
1W Performance:
+4.90%
1M Performance:
+4.90%
6M Performance:
-13.71%
1Y Performance:
+33.77%
1-Day Range:
$0.96
$1.21
1-Week Range:
$0.9369
$1.21
52-Week Range:
$0.48
$1.66
Icecure Medical Ltd Stock (ICCM) Company Profile
Compare ICCM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
1.07 | 58.92M | 3.67M | -13.83M | -10.79M | -0.28 |
|
ABT
Abbott Laboratories
|
126.54 | 218.59B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.14 | 157.13B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
403.53 | 151.59B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.94 | 118.29B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.00 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Icecure Medical Ltd Stock (ICCM) Latest News
ICCM Stock Update: Exploring Current Momentum - timothysykes.com
IceCure Medical (ICCM) Showcases Promising Breast Cancer Data at Tokyo Conference | ICCM Stock News - GuruFocus
IceCure Medical’s Surprising Financial Moves - timothysykes.com
IceCure's ProSense® Featured at Japanese Breast Cancer Society C - GuruFocus
IceCure's ProSense® Featured at Japanese Breast Cancer Society Conference: Updated Positive Clinical Data Shows 99% Recurrence Free Rate with Cryoablation | ICCM Stock News - GuruFocus
Breast Cancer Treatment Shows 99% Success Rate in 17-Year Study | ICCM Stock News - Stock Titan
Is IceCure Medical Ltd a good long term investmentOutstanding risk-reward balance - Autocar Professional
IceCure Reminds Shareholders of Upcoming Expiration of Rights Offering Subscription Period - Barchart.com
IceCure Medical Ltd Stock Analysis and ForecastSuperior portfolio returns - Autocar Professional
What drives IceCure Medical Ltd stock priceOutstanding capital returns - jammulinksnews.com
What analysts say about IceCure Medical Ltd stockConsistent high-performance stocks - Autocar Professional
autocarpro> 2025> IceCure Medical Ltd Stock Analysis and ForecastPhenomenal trading returns - Autocar Professional
What institutions are buying IceCure Medical Ltd stock nowFree Exclusive Investment Tips - Newser
IceCure Medical schedules annual and special shareholder meeting for August 20 - Investing.com Nigeria
IceCure Medical Announces Shareholder Meeting for August 2025 - TipRanks
IceCure Medical schedules annual and special shareholder meeting for August 20 By Investing.com - Investing.com South Africa
Why IceCure Medical Ltd stock attracts strong analyst attentionMarket Beating Strategy - Newser
How IceCure Medical Ltd stock performs during market volatilityStable Stocks With High Yield - Newser
What makes IceCure Medical Ltd stock price move sharplyWeekly Big Movers - Newser
IceCure Medical (NASDAQ:ICCM) Downgraded by Wall Street Zen to “Sell” - Defense World
IceCure Announces Commencement of Rights Offering | ICCM Stock N - GuruFocus
DallasNews (DALN) to be acquired by Hearst for $14 cash per share | ICCM SEC FilingForm 6-K - Stock Titan
IceCure Announces Commencement of Rights Offering - Nasdaq
IceCure Medical Ltd's (NASDAQ:ICCM) Path To Profitability - simplywall.st
Head-To-Head Survey: IceCure Medical (NASDAQ:ICCM) versus Surgery Partners (NASDAQ:SGRY) - Defense World
IceCure Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 2025 - Longview News-Journal
IceCure Medical Reports 24% Revenue Drop: Middle East Conflict Impacts Global Shipments - Stock Titan
IceCure Medical (NASDAQ:ICCM) shareholders have earned a 51% CAGR over the last five years - Yahoo.co
Icecure Medical Ltd Stock (ICCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):